Molecular machine

A molecular machine, or nanomachine,[1] refers to any discrete number of molecular components that produce quasi-mechanical movements (output) in response to specific stimuli (input).[2] The expression is often more generally applied to molecules that simply mimic functions that occur at the macroscopic level. The term is also common in nanotechnology where a number of highly complex molecular machines have been proposed that are aimed at the goal of constructing a molecular assembler. Molecular machines can be divided into two broad categories; synthetic and biological.

The 2016 Nobel Prize in Chemistry was awarded to Jean-Pierre Sauvage, Sir J. Fraser Stoddart and Bernard L. Feringa for the design and synthesis of molecular machines.[3][4]

Examples

From a synthetic perspective, there are two important types of molecular machines: molecular switches (or shuttles) and molecular motors. The major difference between the two systems is that a switch influences a system as a function of state, whereas a motor influences a system as a function of trajectory. A switch (or shuttle) may appear to undergo translational motion, but returning a switch to its original position undoes any mechanical effect and liberates energy to the system. Furthermore, switches cannot use chemical energy to repetitively and progressively drive a system away from equilibrium whereas a motor can.

Synthetic

A wide variety of rather simple molecular machines have been synthesized by chemists. They can consist of a single molecule; however, they are often constructed for mechanically-interlocked molecular architectures, such as rotaxanes and catenanes. Carbon nanotube nanomotors have also been produced.[5]

Biological

Some biological molecular machines

The most complex molecular machines are proteins found within cells. These include motor proteins, such as myosin, which is responsible for muscle contraction, kinesin, which moves cargo inside cells away from the nucleus along microtubules, and dynein, which produces the axonemal beating of motile cilia and flagella. These proteins and their nanoscale dynamics are far more complex than any molecular machines that have yet been artificially constructed.

Probably the most significant biological machine known is the ribosome. Other important examples include motile cilia. A high-level-abstraction summary is that, "[i]n effect, the [motile cilium] is a nanomachine composed of perhaps over 600 proteins in molecular complexes, many of which also function independently as nanomachines."[1] Flexible linker domains allow the connecting protein domains to recruit their binding partners and induce long-range allostery via protein domain dynamics.[7]

This protein flexibility allows the construction of biological machines. The first useful applications of these biological machines might be in nanomedicine. For example,[8] they could be used to identify and destroy cancer cells.[9][10] Molecular nanotechnology is a speculative subfield of nanotechnology regarding the possibility of engineering molecular assemblers, biological machines which could re-order matter at a molecular or atomic scale. Nanomedicine would make use of these nanorobots, introduced into the body, to repair or detect damages and infections. Molecular nanotechnology is highly theoretical, seeking to anticipate what inventions nanotechnology might yield and to propose an agenda for future inquiry. The proposed elements of molecular nanotechnology, such as molecular assemblers and nanorobots are far beyond current capabilities.[11][12]

Research

The construction of more complex molecular machines is an active area of theoretical research. A number of molecules, such as molecular propellers, have been designed, although experimental studies of these molecules are inhibited by the lack of methods to construct these molecules. In this context, theoretical modeling can be extremely useful to understand the self-assembly/disassembly processes of rotaxanes, important for the construction of light-powered molecular machines.[13] This molecular-level knowledge may foster the realization of ever more complex, versatile, and effective molecular machines for the areas of nanotechnology, including molecular assemblers.

References

  1. 1 2 Satir, Peter; Søren T. Christensen (2008-03-26). "Structure and function of mammalian cilia". Histochemistry and Cell Biology. Springer Berlin / Heidelberg. 129 (6): 688. doi:10.1007/s00418-008-0416-9. PMC 2386530Freely accessible. PMID 18365235. 1432-119X. Retrieved 2009-09-11.
  2. Ballardini R, Balzani V, Credi A, Gandolfi MT, Venturi M (2001). "Artificial Molecular-Level Machines: Which Energy To Make Them Work?". Acc. Chem. Res. 34 (6): 445–455. doi:10.1021/ar000170g.
  3. Staff (5 October 2016). "The Nobel Prize in Chemistry 2016". Nobel Foundation. Retrieved 5 October 2016.
  4. Chang, Kenneth; Chan, Sewell (5 October 2016). "3 Makers of 'World's Smallest Machines' Awarded Nobel Prize in Chemistry". New York Times. Retrieved 5 October 2016.
  5. Fennimore, A. M.; T.D. Yuzvinsky; Wei-Qiang Han; M. S. Fuhrer; J. Cumings & A. Zettl (2003). "Rotational actuators based on carbon nanotubes". Nature. 424 (6947): 408–410. Bibcode:2003Natur.424..408F. doi:10.1038/nature01823. PMID 12879064.
  6. Cavalcanti A, Shirinzadeh B, Freitas Jr RA, Hogg T (2008). "Nanorobot architecture for medical target identification". Nanotechnology. 19 (1): 015103(15pp). Bibcode:2008Nanot..19a5103C. doi:10.1088/0957-4484/19/01/015103.
  7. Bu Z, Callaway DJ (2011). "Proteins MOVE! Protein dynamics and long-range allostery in cell signaling". Advances in Protein Chemistry and Structural Biology. Advances in Protein Chemistry and Structural Biology. 83: 163–221. doi:10.1016/B978-0-12-381262-9.00005-7. ISBN 9780123812629. PMID 21570668.
  8. Amrute-Nayak, M.; Diensthuber, R. P.; Steffen, W.; Kathmann, D.; Hartmann, F. K.; Fedorov, R.; Urbanke, C.; Manstein, D. J.; Brenner, B.; Tsiavaliaris, G. (2010). "Targeted Optimization of a Protein Nanomachine for Operation in Biohybrid Devices". Angewandte Chemie. 122 (2): 322–326. doi:10.1002/ange.200905200.
  9. Patel, G. M.; Patel, G. C.; Patel, R. B.; Patel, J. K.; Patel, M. (2006). "Nanorobot: A versatile tool in nanomedicine". Journal of Drug Targeting. 14 (2): 63–7. doi:10.1080/10611860600612862. PMID 16608733.
  10. Balasubramanian, S.; Kagan, D.; Jack Hu, C. M.; Campuzano, S.; Lobo-Castañon, M. J.; Lim, N.; Kang, D. Y.; Zimmerman, M.; Zhang, L.; Wang, J. (2011). "Micromachine-Enabled Capture and Isolation of Cancer Cells in Complex Media". Angewandte Chemie International Edition. 50 (18): 4161–4164. doi:10.1002/anie.201100115.
  11. Freitas, Robert A., Jr.; Havukkala, Ilkka (2005). "Current Status of Nanomedicine and Medical Nanorobotics" (PDF). Journal of Computational and Theoretical Nanoscience. 2 (4): 1–25. doi:10.1166/jctn.2005.001.
  12. Nanofactory Collaboration
  13. Tabacchi, G.; Silvi, S.; Venturi, M.; Credi, A.; Fois, E. (2016). "Dethreading of a Photoactive Azobenzene-Containing Molecular Axle from a Crown Ether Ring: A Computational Investigation". ChemPhysChem. doi:10.1002/cphc.201501160.
This article is issued from Wikipedia - version of the 10/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.